Liu, Yue
Chen, Xilin
Gao, Beiyao
Chen, Xi
Xie, Zhi
Luo, Dan
Funding for this research was provided by:
National Natural Science Foundation of China (81202290)
National Natural Science Foundation of Hunan Province (2019J40401)
Article History
Received: 30 July 2025
Accepted: 2 April 2026
First Online: 22 April 2026
Declarations
:
: The baseline and one-year follow-up studies were approved by the IEC of the Institute of Clinical Pharmacology of Central South University (CTXY-120033-3). The five-year and nine-year follow-up studies were approved by the Human Research Ethics Committee of Xiangya School of Public Health (XYGW-2018-055, XYGW-2022-31). Written informed consent was acquired from all participants. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.